Doug Kass shares his views every day on RealMoneyPro. Click here for a real-time look at his insights and musings.

 

  

TFANGs Redux
 
Originally published at 11:50 a.m. EST on March 3, 2016
 
I'm currently short Telsa  ( TSLA) , Amazon  ( AMZN) and Netflix  ( NFLX) -- three of the five components of the TFANGs.

This chart from Steve Cortes of BGC shows that the FANGs (the TFANGs minus Tesla) are starting to approach a pivotal technical position and have begun to exhibit some erosion in relative performance:


Source: BGC

Position: Short QQQ, TSLA (small), AMZN (small), NFLX (small)
 

 
Selling Biotechs for Some Nice Gains
 
Originally published at 11:40 a.m. EST on March 2, 2016
 
I'm reducing the size of my biotech basket by selling across the board following some very large gains. In fact, I expect to completely eliminate my holdings if we see any further increases.

Today's gains have been truly breathtaking. We've seen 5% to 10% rises in Acadia Pharmaceuticals  (ACAD) and Aerie Pharmaceuticals  (AERI) , while Cempr (CEMP) , Intrexon  (XON) , Portola Pharmaceuticals  (PTLA) and Sage Therapeutics  (SAGE) are all up around $3 a share or more.

Position: Long XON, ACAD (small), AERI (small), CELG (small), CEMP (small), GILD (small), NKTR (small), NVAX (small), OTIC (small), PTLA (small), SAGE (small), TTPH (small)

At the time of publication, Kass and/or his funds were short TSLA, AMZN, NFLX, and long XON, ACAD (small), AERI (small), CELG (small), CEMP (small), GILD (small), NKTR (small), NVAX (small), OTIC (small), PTLA (small), SAGE (small), TTPH (small,) although holdings can change at any time.

Doug Kass is the president of Seabreeze Partners Management Inc. Under no circumstances does this information represent a recommendation to buy, sell or hold any security.

More from Investing

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

Neel Kashkari: The Heart of Our Financial System Is More Radioactive Than Ever

McDonald's Criticized for Not Doing More in Wake of Sexual Harassment Claims

McDonald's Criticized for Not Doing More in Wake of Sexual Harassment Claims

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%